Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.

Literature DB >> 33270134

Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.

Daniel Poston^1,2, Yiska Weisblum¹, Helen Wise³, Kate Templeton³, Sara Jenks³, Theodora Hatziioannou¹, Paul Bieniasz^1,4.

Abstract

Cross-reactive immune responses elicited by seasonal coronaviruses might impact SARS-CoV-2 susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in pre-pandemic sera from patients with prior PCR-confirmed seasonal coronavirus infection. While neutralizing activity against seasonal coronaviruses was detected in nearly all sera, cross-reactive neutralizing activity against SARS-CoV-2 was undetectable.

Entities: CellLine Chemical Disease Gene Species

Keywords: COVID19; SARS-CoV-2; Seasonal coronavirus; antibodies; neutralization

Year: 2020 PMID： 33270134 DOI： 10.1093/cid/ciaa1803

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

26 in total

1. Family matters for coronavirus disease and vaccines.

Authors: David J Bean; Manish Sagar
Journal: J Clin Invest Date: 2021-12-15 Impact factor: 14.808

2. Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.

Authors: Lindsay McDonald; Helen Wise; Frauke Muecksch; Daniel Poston; Sally Mavin; Kate Templeton; Elizabeth Furrie; Claire Richardson; Jaqueline McGuire; Lisa Jarvis; Kristen Malloy; Andrew McAuley; Norah Palmateer; Elizabeth Dickson; Theodora Hatziioannou; Paul Bieniasz; Sara Jenks
Journal: J Clin Virol Plus Date: 2021-06-14

3. COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins.

Authors: Evan A Elko; Georgia A Nelson; Heather L Mead; Erin J Kelley; Sophia T Carvalho; Nathan G Sarbo; Caroline E Harms; Virginia Le Verche; Angelo A Cardoso; Jennifer L Ely; Annalee S Boyle; Alejandra Piña; Sierra N Henson; Fatima Rahee; Paul S Keim; Kimberly R Celona; Jinhee Yi; Erik W Settles; Daniela A Bota; George C Yu; Sheldon R Morris; John A Zaia; Jason T Ladner; John A Altin
Journal: Cell Rep Date: 2022-06-13 Impact factor: 9.995

Review 4. Antibody-mediated neutralization of SARS-CoV-2.

Authors: Henning Gruell; Kanika Vanshylla; Timm Weber; Christopher O Barnes; Christoph Kreer; Florian Klein
Journal: Immunity Date: 2022-05-13 Impact factor: 43.474

5. COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins.

Authors: Evan A Elko; Georgia A Nelson; Heather L Mead; Erin J Kelley; Virginia Le Verche; Angelo A Cardoso; Jennifer L Ely; Annalee S Boyle; Alejandra Piña; Sierra N Henson; Fatima Rahee; Paul S Keim; Kimberly R Celona; Jinhee Yi; Erik W Settles; George C Yu; Sheldon R Morris; John A Zaia; Jason T Ladner; John A Altin
Journal: medRxiv Date: 2022-01-25

Review 6. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020).

Authors: David S Kim; Sarah Rowland-Jones; Ester Gea-Mallorquí
Journal: Front Immunol Date: 2020-12-09 Impact factor: 7.561

7. Temporal development and neutralising potential of antibodies against SARS-CoV-2 in hospitalised COVID-19 patients: An observational cohort study.

Authors: Isa Murrell; Donall Forde; Wioleta Zelek; Linda Tyson; Lisa Chichester; Nicki Palmer; Rachel Jones; B Paul Morgan; Catherine Moore
Journal: PLoS One Date: 2021-01-26 Impact factor: 3.752